Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rang în acțiuni #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Preț acțiune
$183.43
Capitalizare de piață
$50.54B
Schimbare (1 zi)
2.13%
Schimbare (1 an)
29.20%
Țară
US
Tranzacționează Becton, Dickinson and Company (BDX)

Categorie

Număr de acțiuni în circulație pentru Becton, Dickinson and Company (BDX)
Număr de acțiuni în circulație la data de June 2026: 274.79M
Conform celor mai recente rapoarte financiare și prețului acțiunilor Becton, Dickinson and Company, numărul curent de acțiuni în circulație este 274.79M. La sfârșitul anului September 2024, compania avea 289.76M acțiuni în circulație. Numărul de acțiuni în circulație este de obicei influențat de splituri de acțiuni și programe de răscumpărare.
Istoricul acțiunilor în circulație pentru Becton, Dickinson and Company (BDX) din 2000 până în 2026
Acțiuni în circulație la sfârșitul fiecărui an
An Acțiuni în circulație Schimbă
2026 (TTM) 274.79M -4.13%
2025 286.61M -1.09%
2024 289.76M 1.22%
2023 286.28M 0.45%
2022 285.01M -1.48%
2021 289.29M 3.70%
2020 278.97M 3.34%
2019 269.94M 4.49%
2018 258.35M 18.00%
2017 218.94M 2.93%
2016 212.70M 5.02%
2015 202.54M 4.78%
2014 193.30M -0.95%
2013 195.16M -5.01%
2012 205.46M -7.11%
2011 221.18M -5.61%
2010 234.33M -2.56%
2009 240.48M -1.57%
2008 244.32M -0.35%
2007 245.19M -0.92%
2006 247.46M -1.62%
2005 251.53M 0.01%
2004 251.51M -1.19%
2003 254.54M -1.37%
2002 258.07M 0.27%
2001 257.37M 1.64%
2000 253.23M 0.00%
Acțiuni în circulație pentru companii similare sau concurente
Companie Acțiuni în circulație Diferență Țara
354.50M 29.01%
US
461.20M 67.84%
FR
- -
JP
- -
CH
- -
US